Latest Nantahala Capital Management, LLC Stock Portfolio
Nantahala Capital Management, LLC Performance:
2024 Q3: 9.04%YTD: 10.02%2023: -2.03%
Performance for 2024 Q3 is 9.04%, and YTD is 10.02%, and 2023 is -2.03%.
About Nantahala Capital Management, LLC and 13F Hedge Fund Stock Holdings
Nantahala Capital Management, LLC is a hedge fund based in NEW CANAAN, CT. On 14-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.5 Billions. In it's latest 13F Holdings report, Nantahala Capital Management, LLC reported an equity portfolio of $2 Billions as of 30 Sep, 2024.
The top stock holdings of Nantahala Capital Management, LLC are SLNO, ESTA, BVS. The fund has invested 8.3% of it's portfolio in SOLENO THERAPEUTICS INC and 5.2% of portfolio in ESTABLISHMENT LABS HLDGS INC.
The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC, DXP ENTERPRISES INC (DXPE) and PERELLA WEINBERG PARTNERS (PWP) stocks. They significantly reduced their stock positions in INSTIL BIO INC (TIL), PATHWARD FINANCIAL INC (CASH) and NEUROGENE INC. Nantahala Capital Management, LLC opened new stock positions in TITAN MACHY INC (TITN), FULCRUM THERAPEUTICS INC (FULC) and POWERSCHOOL HOLDINGS INC (PWSC). The fund showed a lot of confidence in some stocks as they added substantially to VERASTEM INC (VSTM), B. RILEY FINANCIAL INC (RILY) and XTANT MED HLDGS INC (XTNT).
The top stock holdings of Nantahala Capital Management, LLC are SLNO, ESTA, BVS. The fund has invested 8.3% of it's portfolio in SOLENO THERAPEUTICS INC and 5.2% of portfolio in ESTABLISHMENT LABS HLDGS INC.
The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC, DXP ENTERPRISES INC (DXPE) and PERELLA WEINBERG PARTNERS (PWP) stocks. They significantly reduced their stock positions in INSTIL BIO INC (TIL), PATHWARD FINANCIAL INC (CASH) and NEUROGENE INC. Nantahala Capital Management, LLC opened new stock positions in TITAN MACHY INC (TITN), FULCRUM THERAPEUTICS INC (FULC) and POWERSCHOOL HOLDINGS INC (PWSC). The fund showed a lot of confidence in some stocks as they added substantially to VERASTEM INC (VSTM), B. RILEY FINANCIAL INC (RILY) and XTANT MED HLDGS INC (XTNT).
Nantahala Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Nantahala Capital Management, LLC made a return of 9.04% in the last quarter. In trailing 12 months, it's portfolio return was 21.15%.
New Buys
| Ticker | $ Bought |
|---|---|
| titan machy inc | 22,640,100 |
| fulcrum therapeutics inc | 17,057,100 |
| powerschool holdings inc | 13,343,800 |
| blacksky technology inc | 11,613,000 |
| structure therapeutics inc | 7,505,190 |
| amylyx pharmaceuticals inc | 4,550,790 |
| scpharmaceuticals inc | 3,420,000 |
| gogo inc | 3,414,070 |
New stocks bought by Nantahala Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| verastem inc | 366 |
| b. riley financial inc | 183 |
| xtant med hldgs inc | 59.13 |
| eventbrite inc | 5.04 |
Additions to existing portfolio by Nantahala Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| instil bio inc | -92.04 |
| pathward financial inc | -75.6 |
| neurogene inc | -70.75 |
| industrial logistics pptys t | -69.76 |
| luxfer hldgs plc | -65.74 |
| rumbleon inc | -65.28 |
| ocular therapeutix inc | -65.00 |
| imax corp | -64.44 |
Nantahala Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cutera inc | -1,388,000 |
| conns inc | -4,361,030 |
| avadel pharmaceuticals plc | -9,842,000 |
| perella weinberg partners | -6,507,300 |
| dxp enterprises inc | -9,461,930 |
| nikola corp | -1,637,980 |
| an2 therapeutics inc | -422,596 |
| evoke pharma inc | -714,150 |
Nantahala Capital Management, LLC got rid off the above stocks
Sector Distribution
Nantahala Capital Management, LLC has about 59.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 59.1 |
| Consumer Cyclical | 10.8 |
| Others | 10 |
| Technology | 6 |
| Financial Services | 4.8 |
| Communication Services | 4.6 |
| Industrials | 3.5 |
| Real Estate | 1.3 |
Market Cap. Distribution
Nantahala Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 59.5 |
| MICRO-CAP | 19 |
| MID-CAP | 9.3 |
| UNALLOCATED | 9 |
| NANO-CAP | 3.2 |
Stocks belong to which Index?
About 42.1% of the stocks held by Nantahala Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 57.9 |
| RUSSELL 2000 | 42.1 |
Nantahala Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Nantahala Capital Management, LLC
Nantahala Capital Management, LLC has 124 stocks in it's portfolio. About 27.5% of the portfolio is in top 10 stocks. FULC proved to be the most loss making stock for the portfolio. SLNO was the most profitable stock for Nantahala Capital Management, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABEO | abeona therapeutics inc | 1.10 | 3,432,640 | 21,694,300 | reduced | -50.54 | ||
| ACHV | achieve life sciences inc | 0.16 | 654,000 | 3,099,960 | reduced | -50.00 | ||
| ACRX | talphera inc | 0.09 | 1,992,520 | 1,706,790 | reduced | -50.00 | ||
| ALRN | aileron therapeutics inc | 0.08 | 464,367 | 1,643,860 | reduced | -50.00 | ||
| ALTG | alta equipment group inc | 0.29 | 845,115 | 5,696,080 | reduced | -49.59 | ||
| AMLX | amylyx pharmaceuticals inc | 0.23 | 1,404,560 | 4,550,790 | new | |||
| AMRX | amneal pharmaceuticals inc | 1.12 | 2,669,940 | 22,213,900 | reduced | -50.00 | ||
| ANEB | anebulo pharmaceuticals inc | 0.05 | 511,073 | 986,371 | reduced | -50.00 | ||
| ANTX | an2 therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APRE | aprea therapeutics inc | 0.03 | 205,760 | 565,840 | reduced | -50.00 | ||
| APTO | aptose biosciences inc | 0.00 | 77,340 | 31,779 | reduced | -50.00 | ||
| ASPS | altisource portfolio solns s | 0.07 | 1,091,010 | 1,309,210 | reduced | -50.00 | ||
| ASRT | assertio holdings inc | 0.53 | 8,948,340 | 10,559,000 | reduced | -51.74 | ||
| ATXS | astria therapeutics inc | 0.38 | 675,000 | 7,431,750 | reduced | -50.00 | ||
| AURA | aura biosciences inc | 0.57 | 1,270,040 | 11,316,000 | reduced | -50.00 | ||
| AYTU | aytu biopharma inc | 0.13 | 1,086,810 | 2,554,010 | reduced | -50.00 | ||
| AZYO | elutia inc | 0.55 | 2,864,950 | 10,915,400 | reduced | -20.23 | ||
| BCOV | brightcove inc | 0.18 | 1,664,770 | 3,595,900 | reduced | -36.64 | ||
| BIL | spdr ser tr | 0.11 | 21,646 | 2,138,620 | reduced | -51.62 | ||
| BKSY | blacksky technology inc | 0.59 | 2,450,000 | 11,613,000 | new | |||